Discovery and Research
Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity Pathway Analysis - June 17 2021
597 views
Specifically, for conditions of interest (diseases, cell lines, treatments etc.), we will discuss how to:
• Identify public studies of interest
• Derive a biomarker/gene signature
• Study expression of a gene or drug target
• Correlate expression of multiple genes and biomarkers
• Visualize a gene signature in the context of a heatmap
• Compare public data with other public data or a user’s own data
Speaker: Sumana Chintalapudi, Ph.D., Field Application Scientist, QIAGEN Digital Insights
Related videos
Discovery and Research
Multi-omic changes in the postnatal mouse heart identified by QIAGEN Ingenuity Pathway Analysis...
Multi-omics experiments allow researchers to make important discoveries in...
Discovery and Research
Using QIAGEN Digital Insights to determine how LY6E impairs coronavirus fusion and confers immune...
Zoonotic coronaviruses (CoVs) are significant threats to global health, as...
Discovery and Research
Transcriptomics, Proteomics and Metabolic Changes in Post-Natal Mouse Heart analyzed with...
In this talk, Jean-Noël Billaud, Ph.D. Senior Principal Scientist, QIAGEN...
Discovery and Research
Exploring Single-Cell Transcriptomes Using Bioinformatics Solutions from QIAGEN - Part 1
Cells – the basic building blocks of organisms – are each quite unique....